Hopital de la cote Basque

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma1 trial
• Ovarian cancer1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• ARCAGY/ GINECO GROUP1 trial
• Intergroupe Francophone du Myelome1 trial

Running trials

• Recruiting

  Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery

  NCT06476184· Phase 3· ARCAGY/ GINECO GROUP· Source

  Contact: Thomas GRELLETY

• Active, not recruiting

  Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients

  NCT06062537· Intergroupe Francophone du Myelome· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ovarian cancer1 recruiting